Every 8-K that Zevia Pbc (ZVIA) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ZVIA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ZVIA filings page.
Zevia PBC reported second-quarter 2026 results with net sales of $45.0 million, up 1.1% year over year, driven by pricing while volume declined 3.7% against prior-year distribution load-ins. Gross margin was 48.9%, up 0.2 percentage points as pricing gains offset higher aluminum costs.
Operating expenses reflected higher marketing and personnel spending, restructuring and increased equity-based compensation, including awards under a Cardi B brand endorsement agreement. Net loss widened to $2.9 million, or $0.04 per share, versus $0.7 million, while adjusted net loss was $1.8 million. Adjusted EBITDA improved to $0.5 million from $0.2 million. First-half 2026 net sales grew 10.4%, highlighting earlier-period strength.
The company ended June 30, 2026 with $28.5 million of cash and no debt, plus a $20 million unused credit line. Net cash provided by operating activities for the first half was $3,950 (in thousands). For full-year 2026, Zevia maintains net sales guidance of $170 million–$175 million and an adjusted EBITDA loss of $2.0 million–$4.0 million, and for third-quarter 2026 expects net sales of $44.0 million–$46.0 million with an adjusted EBITDA loss of $3.0 million–$3.5 million.
Zevia PBC held its 2026 Annual Meeting of Stockholders on June 10, 2026. As of the record date, there were 71,716,158 shares of Class A common stock and 5,208,885 shares of Class B common stock outstanding, each entitled to one vote per share.
Director nominees received the following votes: Suzanne S. Ginestro had 38,876,932 votes for, 2,008,295 against, 29,845 abstentions and 20,013,658 broker non-votes. David J. Lee had 36,046,637 votes for, 4,837,211 against, 31,224 abstentions and 20,013,658 broker non-votes. Another proposal received 58,295,745 votes for, 2,335,147 against and 297,838 abstentions.
Zevia PBC announced a leadership change, with President and CEO Amy E. Taylor resigning effective mid-June 2026 and remaining as a director and short-term consultant. The board appointed current director Alexandre I. Ruberti as the new President and Chief Executive Officer.
Ruberti’s offer includes a $638,000 annual base salary, target bonus equal to 100% of salary, and 2026 long-term equity awards of $1,440,000 in restricted stock units vesting over four years and $360,000 in performance stock units tied to net sales through December 31, 2028. He is also eligible for future annual long-term incentive awards of $1,800,000 and a $50,000 relocation allowance, plus severance protections that generally provide 12 months of base salary and COBRA subsidies if he is terminated without cause or resigns for good reason. Separately, Zevia revised its second quarter 2026 outlook, now expecting net sales at the high end of prior guidance and Adjusted EBITDA at or above its earlier range.
Zevia PBC disclosed that its subsidiary Zevia LLC entered into a First Amendment to its Loan and Security Agreement with Bank of America and other lenders. The amendment extends the maturity of the secured revolving line of credit to February 22, 2030 and reduces the credit spread adjustment on the Term Secured Overnight Financing Rate margin to 0.10%. It also updates financial covenants, including a minimum liquidity requirement of $7,000,000 until the company achieves a fixed charge coverage ratio of at least 1.00 to 1.00 for two consecutive fiscal quarters or six consecutive months. In addition, a minimum fixed charge coverage ratio of 1.00 to 1.00 applies following certain events of default or when availability falls below the greater of $3 million and 17.5% of the borrowing base, and must be met until availability remains above that threshold for 30 consecutive days.
Zevia PBC reported strong first quarter 2026 results with faster growth and sharply lower losses. Net sales rose 21.2% year over year to $46.1 million, driven mainly by 20.4% volume growth from expanded Club, Mass and e-commerce distribution.
Gross margin was 48.4%, down from 50.1% as higher aluminum costs weighed on profitability. Net loss narrowed to $2.4 million, or $0.03 per share, compared with a $6.4 million loss a year earlier. Adjusted net loss improved to $0.1 million, and Adjusted EBITDA turned positive at $0.9 million versus a $3.3 million loss. The company ended the quarter with $26.6 million in cash, no debt, and an unused $20 million credit line.
Zevia PBC reported fourth-quarter and full-year 2025 results showing modest growth and much smaller losses. Full-year net sales rose 4.0% to $161.3 million, while gross margin improved to 48.0% from 46.4%. Net loss narrowed to $11.2 million from $23.8 million, and Adjusted EBITDA loss improved to $4.7 million from $15.2 million.
In the fourth quarter, net sales declined 4.0% to $37.9 million, mainly from lower volumes after prior distribution expansion and reduced promotions. Quarterly net loss shrank to $1.3 million, and Adjusted EBITDA turned slightly positive at about $0.05 million.
Zevia ended 2025 with $25.4 million in cash, no debt, and an unused $20 million credit line. For 2026, it expects net sales of $169–$173 million and Adjusted EBITDA between a $1.0 million loss and a $0.5 million gain. The company also named Lead Independent Director Andrew Ruben as Chair of the board.
Zevia PBC reported changes to its board of directors. The board appointed Suzanne Ginestro as an independent Class II director effective January 7, 2026, with her term running until the company’s 2026 annual meeting of stockholders, when she will be eligible for re-election. She will also serve on the board’s Compensation Committee and receive the standard compensation provided to non-employee directors, as described in the company’s 2025 annual meeting proxy statement.
The company also disclosed that director Justin Shaw notified Zevia on January 7, 2026 that he will step down from the board effective February 24, 2026. His resignation is not due to any disagreement with the company or the board over operations, policies, or practices. Zevia expects Ms. Ginestro to enter into its standard director and officer indemnification agreement and stated there are no related-party transactions requiring disclosure.
Zevia PBC furnished an 8‑K announcing its earnings release for the third quarter ended September 30, 2025. The company made the release available as Exhibit 99.1, dated November 5, 2025.
The information under Item 2.02, including Exhibit 99.1, is furnished and not deemed “filed” under Section 18 of the Exchange Act, and is not incorporated by reference unless expressly stated in a future filing. The report was signed by Girish Satya, Chief Financial Officer and Principal Accounting Officer.
Zevia PBC filed an 8-K reporting that it posted an Investor Presentation to its investor website on August 25, 2025 and attached the presentation as Exhibit 99.1. The company said it may use the presentation, in whole or in part and possibly modified, in investor and analyst presentations on and after August 26, 2025. The filing states the presentation is summary information to be read with the company’s SEC filings and public announcements and contains forward-looking statements subject to customary cautionary language. The filing also notes the furnished items are not "filed" for certain legal liability purposes.
Zevia PBC entered into an Equity Distribution Agreement to sell up to $20,000,000 of its Class A common stock through Piper Sandler as sales agent in an at-the-market offering. The Agent will receive a commission equal to 3.0% of gross sales and has agreed to use commercially reasonable efforts to sell shares; with the Company’s consent, the Agent may also use other lawful sale methods. All shares offered will be issued under the Company’s existing Form S-3 shelf registration and related prospectus supplements. The Company has no obligation to sell and may suspend sales at any time.
The Company intends to use net proceeds, after commissions and expenses, to purchase newly issued Class A units of Zevia LLC at per-unit prices equal to the per-share offering price and for investments in marketing and sales, growth through acquisitions of businesses or assets, and general corporate purposes including working capital and capital expenditures. The agreement includes customary representations, indemnities and expense reimbursement provisions and may be terminated by either party on prior notice.